Study of DPPG2-TSL-DOX Combined with Hyperthermia in Soft Tissue Sarcoma
Phase 1
Active, not recruiting
- Conditions
- Sarcoma, Soft Tissue
- Interventions
- Drug: DPPG2-TSL-DOX
- First Posted Date
- 2023-05-15
- Last Posted Date
- 2025-02-21
- Lead Sponsor
- Thermosome GmbH
- Target Recruit Count
- 9
- Registration Number
- NCT05858710
- Locations
- 🇩🇪
Helios Klinikum Berlin-Buch GmbH, Berlin, Germany
🇩🇪Klinikum der Universität München (KUM) Campus Großhadern, Munich, Germany
© Copyright 2025. All Rights Reserved by MedPath